Miki Takami | Department of Neuroscience and Neurology, Osaka City University Medical School
スポンサーリンク
概要
- Miki Takamiの詳細を見る
- 同名の論文著者
- Department of Neuroscience and Neurology, Osaka City University Medical Schoolの論文著者
関連著者
-
Miki Takami
Department of Neuroscience and Neurology, Osaka City University Medical School
-
Miki Takami
Department Of Geriatric Medicine Osaka City University Graduate School Of Medicine
-
Morioka Tomoaki
Metabolism Endocrinology And Molecular Medicine Department Of Internal Medicine Osaka City University Graduate School Of Medicine
-
MIKI Takami
Department of Geriatric Medicine and Neurology, Osaka City University Graduate School of Medicine
-
Nishizawa Yoshiki
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate Schoo
-
Nishizawa Yoshiki
Department Of Metabolism Endocrinology And Molecular Medicine Osaka City University Graduate School
-
Na Y
Department Of Metabolism Endocrinology And Molecular Medicine Osaka City University Graduate School
-
Nakatsuka Kiyoshi
Department Of Metabolism Endocrinology And Molecular Medicine Osaka City University Graduate School
-
Nishizawa Yoshiki
Department Of Metabolism Endocrinology And Molecular Medicine Osaka City University Graduate School Of Medicine
-
NAKA HIROSHI
Department of Geriatric Medicine, Osaka City University Graduate School of Medicine
著作論文
- <Symposium IV>Oligomeric Aβ is the sole culprit molecule to cause Alzheimer's disease?
- Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
- Vitamin K_2 (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis
- Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis
- Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy ; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline
- Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate : advantage of free form of DPD over total DPD in predicting treatment efficacy
- Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
- Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects
- Effects of Deabetes on Uremic Dyslipidemia
- Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis